Clinical Trial Update: A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 pilot study evaluating boceprevir for genotype 6 hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: St Vincent's Hospital Melbourne | Conditions: Chronic Hepatitis C | Phase 2 | Status: UNKNOWN